Chinese population may require further venetoclax dose reduction beyond guidelines when combined with voriconazole: real-world evidence from China.

Front Pharmacol · 2025 · PMC12162294 · PMID 40520199

Europe PMC DOI

hedged sentences

0.0680

closest p · 1.4× alpha

0.0680

boldest claim

The sentences

an increasing trendp = 0.068so close (0.05 < p ≤ 0.1)

Hospitalization costs for VEN 100 mg + VOR are higher than for VEN 400 mg alone or VEN 100 mg + POS Hospitalization costs exhibit an increasing trend in the VEN 400 mg, VEN 100 mg + POS, and VEN 100 mg + VOR (73,513 vs. 91,667 vs. 140,469, p = 0.068 ).

also in 63,971 other papers

did not reach statistical significanceno p-value reported

However, these intergroup differences did not reach statistical significance ( Figure 5 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.